Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CDNL | MYRG |
|---|---|---|
| Price | $26.07 | $313.08 |
| Change today | ▼ 9.23% | ▼ 3.52% |
| Market cap | $532.57M | $4.87B |
| Return, 3 months | -63.1% | -27.3% |
| Return, year to date | +7.8% | +43.3% |
| Return, 1 year | – | +51.2% |
| P/E (TTM) | 68.2 | 29.7 |
| P/B | 2.2 | 6.5 |
| P/E percentile vs own 5y | – | 57th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +20.1% |
| Net profit growth (YoY) | – | +88.4% |
| Gross margin | – | 12.5% |
| Operating margin | – | 5.5% |
| Net margin | – | 4.1% |
| Return on equity | – | 24.7% |
| Analyst target vs. price | +107.1% | +52.8% |
| Analyst buy share | 100% | 67% |
| RSI (14) | 32 | 58 |
| 30-day volatility | 72.0% | 43.1% |
| Max drawdown, 1 year | -72.4% | -45.9% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
